Evidence map›Paper›PMID 42003582›Full record

ArticleAntimicrobial agents and chemotherapy2026

CRISPRi-mediated

Rashmi Gupta, Breven S Simcox, Kyle H Rohde

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Secreted proteins ofFrontiers in tuberculosis · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rashmi GuptaDivision of Immunity and Pathogenesis, College of Medicine, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida, USA.ORCID 0000-0002-2196-3397
Breven S SimcoxDivision of Immunity and Pathogenesis, College of Medicine, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida, USA.
Kyle H RohdeDivision of Immunity and Pathogenesis, College of Medicine, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida, USA.ORCID 0000-0001-9838-3238

Funding

CRISPRi-based discovery and in vivo validation of drug targets in M. abscessusR21AI156221 · NIAID · UNIVERSITY OF CENTRAL FLORIDA · PI ROHDE, KYLE H · 2021 to 2022
$418k
NIH HHS R21AI156221
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene SilencingMycobacterium abscessusMycobacterium Infections, NontuberculousAnimalsBacterial ProteinsFemaleMiceMice, Inbred C57BLMice, Inbred NODMice, SCIDBacterial ProteinsCRiftsZgene regulationMycobacterium abscessussilencing

Identifiers

PMID42003582
PMCPMC13231894

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.